Cetera Investment Advisers Profound Medical Corp. Transaction History
Cetera Investment Advisers
- $41.3 Billion
- Q1 2024
A detailed history of Cetera Investment Advisers transactions in Profound Medical Corp. stock. As of the latest transaction made, Cetera Investment Advisers holds 11,769 shares of PROF stock, worth $100,978. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,769Holding current value
$100,978% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PROF
# of Institutions
44Shares Held
8.97MCall Options Held
34.3KPut Options Held
2.8K-
Gagnon Securities LLC1.53MShares$13.1 Million3.13% of portfolio
-
Fil LTD Hamilton, D01.35MShares$11.6 Million0.01% of portfolio
-
Letko, Brosseau & Associates Inc Montreal, A81.23MShares$10.6 Million0.19% of portfolio
-
Timelo Investment Management Inc.856KShares$7.34 Million2.85% of portfolio
-
Gagnon Advisors, LLC747KShares$6.41 Million5.62% of portfolio
About Profound Medical Corp.
- Ticker PROF
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,851,300
- Market Cap $179M
- Description
- Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...